Статті в журналах з теми "B-cell malignancie"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "B-cell malignancie".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Miao, Miao, Wu Depei, Aining Sun, Ying Wang, Lingzhi Yan, and Qian Wu. "The Efficacy and Safety of Recombinant Human Thrombopoietin in Patients with Hematological Malgnancies After Allogeneic Hematopoietic Stem Cell Transplantation." Blood 118, no. 21 (November 18, 2011): 4565. http://dx.doi.org/10.1182/blood.v118.21.4565.4565.
Повний текст джерелаLydyard, Peter M., Andrew P. Jewell, Christoph Jamin, and Pierre Y. Youinou. "CD5 B cells and B-cell malignancies." Current Opinion in Hematology 6, no. 1 (January 1999): 30. http://dx.doi.org/10.1097/00062752-199901000-00006.
Повний текст джерелаZweidler-McKay, Patrick A., Yiping He, Lanwei Xu, Carlos G. Rodriguez, Fredrick G. Karnell, Andrea C. Carpenter, Jon C. Aster, David Allman, and Warren S. Pear. "Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies." Blood 106, no. 12 (December 1, 2005): 3898–906. http://dx.doi.org/10.1182/blood-2005-01-0355.
Повний текст джерелаBrudno, Jennifer N., Robert P. T. Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, et al. "Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease." Journal of Clinical Oncology 34, no. 10 (April 1, 2016): 1112–21. http://dx.doi.org/10.1200/jco.2015.64.5929.
Повний текст джерелаRen, Anqi, Xiqin Tong, Na Xu, Tongcun Zhang, Fuling Zhou, and Haichuan Zhu. "CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities." Vaccines 11, no. 1 (January 12, 2023): 165. http://dx.doi.org/10.3390/vaccines11010165.
Повний текст джерелаHudecek, Michael, Thomas M. Schmitt, Sivasubramanian Baskar, Maria Teresa Lupo-Stanghellini, Tetsuya Nishida, Tori N. Yamamoto, Marie Bleakley, et al. "The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor." Blood 116, no. 22 (November 25, 2010): 4532–41. http://dx.doi.org/10.1182/blood-2010-05-283309.
Повний текст джерелаChattaraj, Asmi, Mohammad Ebad Ur Rehman, Israr Khan, Diana Franco, Atif Ibrahim, Razwana Khanam, Nayha Tahir, et al. "Safety and efficacy of allogeneic CAR-T cells in B-cell malignancies: A systematic review and meta-analysis." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e19530-e19530. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e19530.
Повний текст джерелаTonino, Sanne H., Marinus H. J. Van Oers, Rene A. Van Lier, and Marie Jose Kersten. "CMV-Associated Expansion of CD8+CD45RA+CD27− T-Cells in Patients with B-Cell Malignancies." Blood 110, no. 11 (November 16, 2007): 3592. http://dx.doi.org/10.1182/blood.v110.11.3592.3592.
Повний текст джерелаIncrocci, Ryan, Molly McCormack, and Michelle Swanson-Mungerson. "Epstein–Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas." Journal of General Virology 94, no. 5 (May 1, 2013): 1127–33. http://dx.doi.org/10.1099/vir.0.049221-0.
Повний текст джерелаPrakash, Ajay, and Alhossain A. Khalafallah. "Concurrent Hairy Cell Leukemia and Metastatic Merkel Cell Carcinoma." Case Reports in Oncological Medicine 2018 (November 14, 2018): 1–6. http://dx.doi.org/10.1155/2018/1736854.
Повний текст джерелаMaio, M., A. Pinto, A. Carbone, V. Zagonel, A. Gloghini, G. Marotta, D. Cirillo, A. Colombatti, F. Ferrara, and L. Del Vecchio. "Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders." Blood 76, no. 4 (August 15, 1990): 783–90. http://dx.doi.org/10.1182/blood.v76.4.783.783.
Повний текст джерелаMaio, M., A. Pinto, A. Carbone, V. Zagonel, A. Gloghini, G. Marotta, D. Cirillo, A. Colombatti, F. Ferrara, and L. Del Vecchio. "Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders." Blood 76, no. 4 (August 15, 1990): 783–90. http://dx.doi.org/10.1182/blood.v76.4.783.bloodjournal764783.
Повний текст джерелаSwanson-Mungerson, Michelle, Ryan Incrocci, Molly McCormack, and Caroline Leof. "Effects of Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) on cytokine production in primary and transformed B cells (105.40)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 105.40. http://dx.doi.org/10.4049/jimmunol.188.supp.105.40.
Повний текст джерелаKochenderfer, James N., Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose, William Telford, Frances T. Hakim, et al. "Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation." Blood 122, no. 21 (November 15, 2013): 151. http://dx.doi.org/10.1182/blood.v122.21.151.151.
Повний текст джерелаDalla Pietà, Anna, Elisa Cappuzzello, Pierangela Palmerini, Annavera Ventura, Andrea Visentin, Giuseppe Astori, Katia Chieregato, et al. "Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells." Journal for ImmunoTherapy of Cancer 9, no. 7 (July 2021): e002475. http://dx.doi.org/10.1136/jitc-2021-002475.
Повний текст джерелаLi, Yangqiu, Lijian Yang, Shaohua Chen, Suxia Geng, Grzegorz Przybylski, and Christian A. Schmidt. "Changes in Thymic Recent Output Function in Patients with B-Cell Lymphocytic Malignancy." Blood 108, no. 11 (November 16, 2006): 4464. http://dx.doi.org/10.1182/blood.v108.11.4464.4464.
Повний текст джерелаLink, BK, and GJ Weiner. "Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells." Blood 81, no. 12 (June 15, 1993): 3343–49. http://dx.doi.org/10.1182/blood.v81.12.3343.bloodjournal81123343.
Повний текст джерелаSud, Amit, Subhayan Chattopadhyay, Hauke Thomsen, Kristina Sundquist, Jan Sundquist, Richard S. Houlston, and Kari Hemminki. "Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk." Blood 134, no. 12 (August 8, 2019): 960–69. http://dx.doi.org/10.1182/blood.2019001362.
Повний текст джерелаGreen, Michael R., and Ash A. Alizadeh. "Common progenitor cells in mature B-cell malignancies." Current Opinion in Hematology 21, no. 4 (July 2014): 333–40. http://dx.doi.org/10.1097/moh.0000000000000049.
Повний текст джерелаYazdani, Yaghoub, Mousa Mohammadnia-Afrouzi, Mehdi Yousefi, Enayat Anvari, Ghasem Ghalamfarsa, Hadi Hasannia, Sanam Sadreddini, and Farhad Jadidi-Niaragh. "Myeloid-derived suppressor cells in B cell malignancies." Tumor Biology 36, no. 10 (September 2, 2015): 7339–53. http://dx.doi.org/10.1007/s13277-015-4004-z.
Повний текст джерелаCooper, Kathrine A., Jonathan Lattell, Beverly Gonzalez, Stephanie Kliethermes, and Sucha Nand. "Prevalence of Multiple Primary Hematologic Malignancies Seen at a Tertiary Care Center." Blood 126, no. 23 (December 3, 2015): 5017. http://dx.doi.org/10.1182/blood.v126.23.5017.5017.
Повний текст джерелаKroeze, Emma, Laura Arias Padilla, Max Bakker, Judith M. Boer, Melanie M. Hagleitner, Birgit Burkhardt, Takeshi Mori, et al. "Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement." Cancers 14, no. 16 (August 12, 2022): 3895. http://dx.doi.org/10.3390/cancers14163895.
Повний текст джерелаLink, BK, and GJ Weiner. "Production and characterization of a bispecific IgG capable of inducing T-cell-mediated lysis of malignant B cells." Blood 81, no. 12 (June 15, 1993): 3343–49. http://dx.doi.org/10.1182/blood.v81.12.3343.3343.
Повний текст джерелаJacobs, Lauren M., Peter H. Wiernik, Janice P. Dutcher, and Pablo Muxi. "Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated Rituximab." Journal of Investigative Medicine High Impact Case Reports 5, no. 1 (January 2017): 232470961769130. http://dx.doi.org/10.1177/2324709617691307.
Повний текст джерелаWeng, Jinsheng, Flavio Egidio Baio, Kelsey E. Moriarty, Hiroki Torikai, Hua Wang, Zhiqiang Liu, Sourindra N. Maiti, et al. "Targeting B-cell malignancies through human B-cell receptor specific CD4+T cells." OncoImmunology 5, no. 11 (September 19, 2016): e1232220. http://dx.doi.org/10.1080/2162402x.2016.1232220.
Повний текст джерелаGhimire, Krishna B., and Binay K. Shah. "Second Primary Malignancy in Diffuse Large B Cell Lymphoma (DLBCL)." Blood 124, no. 21 (December 6, 2014): 2606. http://dx.doi.org/10.1182/blood.v124.21.2606.2606.
Повний текст джерелаSabbah, Shereen, Ya Jankey Jagne, Jianmin Zuo, Thushan de Silva, Mohammad M. Ahasan, Christian Brander, Sarah Rowland-Jones, Katie L. Flanagan, and Andrew D. Hislop. "T-cell immunity to Kaposi sarcoma–associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells." Blood 119, no. 9 (March 1, 2012): 2083–92. http://dx.doi.org/10.1182/blood-2011-07-366476.
Повний текст джерелаZhao, Zhigang, Lin Li, Meelad Dawlaty, Feng Pan, Zhe Li, Yuan Zhou, Hui Shi, et al. "Combined Loss of Tet1 and Tet2 Promotes B-Cell, but Not Myeloid Malignancies in Mice." Blood 126, no. 23 (December 3, 2015): 3650. http://dx.doi.org/10.1182/blood.v126.23.3650.3650.
Повний текст джерелаChintapatla, Rangaswamy, Leticia Varella, Peter Wiernik, Valerie Rusciano, and Janice P. Dutcher. "Association of Renal Cell Carcinoma and B-Cell Hematological Malignancy." Blood 120, no. 21 (November 16, 2012): 5086. http://dx.doi.org/10.1182/blood.v120.21.5086.5086.
Повний текст джерелаZhang, Jenny, Dereje D. Jima, Yuan Gao, Han Wu, Jun Zhu, Mark deLong, Peter E. Lipsky, and Sandeep S. Dave. "Massively Parallel High Throughput Sequencing Identifies Novel Micrornas in Normal and Malignant B Cells." Blood 112, no. 11 (November 16, 2008): 3350. http://dx.doi.org/10.1182/blood.v112.11.3350.3350.
Повний текст джерелаMiletic, Ana V., Amy N. Anzelon-Mills, David M. Mills, Sidne A. Omori, Irene M. Pedersen, Dong-Mi Shin, Jeffrey V. Ravetch, Silvia Bolland, Herbert C. Morse, and Robert C. Rickert. "Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases." Journal of Experimental Medicine 207, no. 11 (October 18, 2010): 2407–20. http://dx.doi.org/10.1084/jem.20091962.
Повний текст джерелаChen, Zhengshan, and Markus Muschen. "Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies." Blood 132, Supplement 1 (November 29, 2018): 1587. http://dx.doi.org/10.1182/blood-2018-99-113674.
Повний текст джерелаLichtman, Eben I., and Gianpietro Dotti. "Chimeric antigen receptor T-cells for B-cell malignancies." Translational Research 187 (September 2017): 59–82. http://dx.doi.org/10.1016/j.trsl.2017.06.011.
Повний текст джерелаMichels, Kathryn R., Alyssa Sheih, Susana A. Hernandez, Alissa H. Brandes, Don Parrilla, Blythe Irwin, Anai M. Perez, et al. "Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering." Journal for ImmunoTherapy of Cancer 11, no. 3 (March 2023): e006292. http://dx.doi.org/10.1136/jitc-2022-006292.
Повний текст джерелаZhang, Jenny, Dereje D. Jima, Cassandra Jacobs, Randy Fischer, Eva Gottwein, Grace Huang, Patricia L. Lugar, et al. "Patterns of microRNA expression characterize stages of human B-cell differentiation." Blood 113, no. 19 (May 7, 2009): 4586–94. http://dx.doi.org/10.1182/blood-2008-09-178186.
Повний текст джерелаYavuz, Selim A., Dan-Paul Hartmann, Said Baidas, Peter E. Lipsky, and Metin Ozdemirli. "Demonstration of Biclonal Chronic Lymphocytic Leukemia with Mutated and Unmutated Clones and Concurrent but Clonally Unrelated Myeloma in the Same Patient by Single Cell Immunoglobulin Heavy and Light Chain Gene Analysis." Blood 104, no. 11 (November 16, 2004): 4772. http://dx.doi.org/10.1182/blood.v104.11.4772.4772.
Повний текст джерелаChen, Weili, Quanzhi Li, Wendy A. Hudson, Ashish Kumar, Nicole Kirchhof, and John H. Kersey. "A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy." Blood 108, no. 2 (July 15, 2006): 669–77. http://dx.doi.org/10.1182/blood-2005-08-3498.
Повний текст джерелаLinden, Michael, Nicole Kirchhof, Cathy Carlson, and Brian Van Ness. "Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies." Blood 103, no. 7 (April 1, 2004): 2779–86. http://dx.doi.org/10.1182/blood-2003-10-3399.
Повний текст джерелаKong, Ling-Yuan, Vaibhav Kapuria, Geoffrey Bartholomeusz, Moshe Talpaz, Waldemar Priebe, and Nicholas J. Donato. "Antitumor Activity and Mechanism of Action of a Novel Stat3 Inhibitor, WP1066, Against Human B-Cell Non-Hodgkin’s Lymphoma and Multiple Myeloma." Blood 106, no. 11 (November 16, 2005): 1489. http://dx.doi.org/10.1182/blood.v106.11.1489.1489.
Повний текст джерелаDas, Manjulika. "Zanubrutinib in B-cell malignancies." Lancet Oncology 20, no. 9 (September 2019): e470. http://dx.doi.org/10.1016/s1470-2045(19)30523-6.
Повний текст джерелаHillis, Jennifer, Michael O’Dwyer, and Adrienne M. Gorman. "Neurotrophins and B-cell malignancies." Cellular and Molecular Life Sciences 73, no. 1 (September 23, 2015): 41–56. http://dx.doi.org/10.1007/s00018-015-2046-4.
Повний текст джерелаNovero, Aileen, Pavan M. Ravella, Yamei Chen, George Dous, and Delong Liu. "Ibrutinib for B cell malignancies." Experimental Hematology & Oncology 3, no. 1 (2014): 4. http://dx.doi.org/10.1186/2162-3619-3-4.
Повний текст джерелаOwen, Carolyn J., and Douglas A. Stewart. "Obinutuzumab for B-cell malignancies." Expert Opinion on Biological Therapy 14, no. 8 (May 23, 2014): 1197–205. http://dx.doi.org/10.1517/14712598.2014.922535.
Повний текст джерелаAbuHilal, Mohanad, Scott Walsh, and Neil Shear. "Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study." Journal of Cutaneous Medicine and Surgery 21, no. 6 (June 14, 2017): 507–12. http://dx.doi.org/10.1177/1203475417716366.
Повний текст джерелаPongas, Georgios, and Bruce D. Cheson. "PI3K signaling pathway in normal B cells and indolent B-cell malignancies." Seminars in Oncology 43, no. 6 (December 2016): 647–54. http://dx.doi.org/10.1053/j.seminoncol.2016.11.011.
Повний текст джерелаElsawa, Sherine F., Anne J. Novak, Deanna M. Grote, Steven C. Ziesmer, Thomas E. Witzig, Robert A. Kyle, Stacey R. Dillon, Brandon Harder, Jane A. Gross, and Stephen M. Ansell. "B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenström macroglobulinemia." Blood 107, no. 7 (April 1, 2006): 2882–88. http://dx.doi.org/10.1182/blood-2005-09-3552.
Повний текст джерелаQian, Jin. "Immune escape mechanism of B-cell malignancies on Anti-CD19 Chimeric Antigen Receptor T-cell treatment and solution." E3S Web of Conferences 271 (2021): 03038. http://dx.doi.org/10.1051/e3sconf/202127103038.
Повний текст джерелаBrown, Jennifer R., Heather Yeckes, Jonathan W. Friedberg, Donna Neuberg, Helen Kim, Lee M. Nadler, and Arnold S. Freedman. "Increasing Incidence of Late Second Malignancies After Conditioning With Cyclophosphamide and Total-Body Irradiation and Autologous Bone Marrow Transplantation for Non-Hodgkin’s Lymphoma." Journal of Clinical Oncology 23, no. 10 (April 1, 2005): 2208–14. http://dx.doi.org/10.1200/jco.2005.05.158.
Повний текст джерелаTaghi Khani, Adeleh, Anil Kumar, Kelly Radecki, Sung June Lee, Mary Lorenson, Xiwei Wu, Zhaohui Gu, Ameae Walker, and Srividya Swaminathan. "Suppressing Synthesis of the Long Isoform of the Prolactin Receptor Is a Targeted Strategy to Prevent and Treat B Cell Malignancies." Blood 138, Supplement 1 (November 5, 2021): 1135. http://dx.doi.org/10.1182/blood-2021-147055.
Повний текст джерелаGreenberg, Zev J., Darlene A. Monlish, Rachel L. Bartnett, and Laura G. Schuettpelz. "Regulation of Homeostatic and Malignant B Cell Development By the Tetraspanin CD53." Blood 132, Supplement 1 (November 29, 2018): 3699. http://dx.doi.org/10.1182/blood-2018-99-111957.
Повний текст джерела